We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
+$307M
Cap. Flow
+$197M
Cap. Flow %
7.22%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
6
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
BIVV
Bioverativ Inc. Common Stock
BIVV
+$67.6M
2
ABBV icon
AbbVie
ABBV
+$63M
3
GILD icon
Gilead Sciences
GILD
+$42.1M
4
PRTA icon
Prothena Corp
PRTA
+$15.7M
5
ALKS icon
Alkermes
ALKS
+$10.3M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.15M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$431B
$860M 31.57%
11,854,758
+937,500
+9% +$63M
PRTA icon
2
Prothena Corp
PRTA
$444M
$617M 22.66%
11,400,424
+294,213
+3% +$15.7M
ALKS icon
3
Alkermes
ALKS
$8.33B
$443M 16.28%
7,647,977
+177,449
+2% +$10.3M
TBPH icon
4
Theravance Biopharma
TBPH
$875M
$427M 15.67%
10,706,180
+1,072
+0% +$41.2K
GILD icon
5
Gilead Sciences
GILD
$168B
$157M 5.77%
2,220,100
+632,000
+40% +$42.1M
BIVV
6
DELISTED
Bioverativ Inc. Common Stock
BIVV
$119M 4.37%
1,977,764
+1,186,500
+150% +$67.6M
BIIB icon
7
Biogen
BIIB
$30.8B
$100M 3.67%
368,645
-8,143
-2% -$2.15M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 0.85% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Woodford Investment Management held 7 positions worth $2.72B, up 13% from $2.42B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management deployed $197M of net new capital in Q2 2017, adding to 6 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Biogen, an estimated $2.15M trimmed.

  • Woodford Investment Management added most to Bioverativ Inc. Common Stock in Q2 2017, an estimated $67.6M increase.
  • Woodford Investment Management's biggest Q2 2017 reduction was Biogen, cutting an estimated $2.15M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $2.72B portfolio in Q2 2017.
  • Woodford Investment Management opened 0 new positions and closed 0 in Q2 2017.
  • Woodford Investment Management's portfolio value rose 13% quarter-over-quarter to $2.72B.

Based on Woodford Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.